This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Young, L. S. Articles by Wilmore, D. W. Search for Related Content PubMed PubMed Citation Articles by Young, L. S. Articles by Wilmore, D. W. Social Bookmarking                         What's this?

Patients Receiving Glutamine-Supplemented Intravenous Feedings Report an Improvement in Mood

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Rancy Bye, RD, MS, CNSD

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Marc Scheltinga, MD

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Thomas R. Ziegler, MD

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Danny O. Jacobs, MD

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Douglas W. Wilmore, MD

Laboratories of Surgical Metabolism and Nutrition, Brigham, Womens Hospital, Harvard Medical School, Boston

Nutritional effects have traditionally focused on outcomes, such as nitrogen balance, wound healing, or muscle strength. Little emphasis has been placed on how biochemical or physical improvements translate into functional changes as perceived by the patient. Because glutamine (GLN)-supplemented nutrition promotes protein synthesis and improves nitrogen balance, we assessed the mood of individuals participating in a randomized controlled blinded trial receiving GLN solutions. Patients (n = 23) undergoing marrow transplantation were randomized by the research pharmacist to receive either standard total parenteral nutrition (TPN) (control) or GLN-containing TPN (40 g of glutamine total). The solutions were isocaloric and isonitrogenous and were administered until the patient was eating 50% of estimated requirements. Before TPN and on admission to the hospital, the patient completed the Profile of Mood States questionnaire, a standardized test quantifying the degree of tension, depression, anger, vigor, fatigue, and confusion. The patient completed the questionnaire again at the end of TPN near discharge. The tests were scored and the change from baseline for each mood for both groups of patients was calculated at the completion of TPN. The scores for vigor in the control group ( scores) decreased over the course of hospitalization as would be expected with a serious illness. The group receiving glutamine TPN, however, essentially showed little change in vigor from baseline and the score was significantly different from the control group ( vigor score -0.85 ± 2.1 in the glutamine group vs -5.90 ± 1.7 in the control group; p = .07). The control group exhibited little change in feelings of anger over the course of hospitalization; however, the glutamine TPN group felt significantly less angry at the completion of TPN than the control group ( anger score -6.2 ± 1.6 in the glutamine group vs -0.5 ± 2.5 in the control group; p = .052). There was a trend for the total mood score (all six moods evaluated together) to exhibit improvement (p = 1). The GLN group also was discharged from the hospital sooner and had fewer infectious episodes. This is one of the first studies to illustrate an improvement in patients' psychosocial status associated with a nutrition intervention. GLN may influence patients' feelings of well-being either directly by affecting central nervous system neurotransmitters or through its effects on the protein status of patients. Psychosocial testing may prove useful in evaluating the functional status of patients receiving nutrition support. (Journal of Parenteral and Enteral Nutrition 17:422-427, 1993)

Journal of Parenteral and Enteral Nutrition, Vol. 17, No. 5, 422-427 (1993)
DOI: 10.1177/0148607193017005422


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. A. August, M. B. Huhmann, and the American Society for Parenteral and Enteral Nu A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation JPEN J Parenter Enteral Nutr, September 1, 2009; 33(5): 472 - 500. [Full Text] [PDF]

				M. Watford Glutamine Metabolism and Function in Relation to Proline Synthesis and the Safety of Glutamine and Proline Supplementation J. Nutr., October 1, 2008; 138(10): 2003S - 2007S. [Abstract] [Full Text] [PDF]

				T. R. Ziegler Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and High Dose Chemotherapy J. Nutr., September 1, 2001; 131(9): 2578S - 2584. [Abstract] [Full Text] [PDF]

				J Powell-Tuck, C P Jamieson, G E A Bettany, O Obeid, H V Fawcett, C Archer, and D L Murphy A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition Gut, July 1, 1999; 45(1): 82 - 88. [Abstract] [Full Text] [PDF]